Clinical Trials List
Protocol NumberTED16132
NCT Number(ClinicalTrials.gov Identfier)-
Completed
2020-12-21 - 2023-12-31
Phase I
Recruiting2
-
-
Trial Applicant
-
Sponsor
-
-
Trial scale
Multi-Regional Multi-Center
-
Update
2026/09/23
Investigators and Locations
Co-Principal Investigator
- Chen-Yuan Lin Division of Hematology & Oncology
- Ching Yun Hsieh Division of Hematology & Oncology
- Ming-Yu Lien Division of Hematology & Oncology
- Che-Hung Lin Division of Hematology & Oncology
- Tzu-Ting Chen Division of Hematology & Oncology
- Ming-Hung Tsai Division of Hematology & Oncology
- Chi-Ching Chen Division of Hematology & Oncology
- Ching-Chan Lin Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Principal Investigator
- -
Co-Principal Investigator
- Shang-Yi Huang Division of Hematology & Oncology
- - - Division of Hematology & Oncology
- MING YAO Division of Hematology & Oncology
- Tai-Chung Huang Division of Hematology & Oncology
- Sheng-chieh Chou Division of Hematology & Oncology
- Chien-Chin Lin Division of Hematology & Oncology
- Shang-Ju Wu Division of Hematology & Oncology
- Huai-Hsuan Huang Division of Hematology & Oncology
- 田豐銘 Division of Hematology & Oncology
The Actual Total Number of Participants Enrolled
0 Recruiting
Study Contacts
- -
Condition/Disease
-
Objectives
-
Test Drug
-
Active Ingredient
-
Dosage Form
-
Dosage
-
Endpoints
-
Inclution Criteria
-
Exclusion Criteria
-
The Estimated Number of Participants
-
Taiwan
10 participants
-
Global
95 participants